Stock ratings for US stocks based on published research signals
Stage
Not given
Startup
Founded
Not given
2025
Based in
US
PL
Pricing model
Not given
Freemium
Pricing
Not given
Free plan with limited access to 200 largest stocks. Paid Tessera plan: $2 for first month, then $29/month, billed monthly. Cancel anytime. 30-day money-back guarantee.
Key features
Publish and share investment takes with portfolio composition
Real-time performance tracking with percentage returns
Social features to view and follow other investors' strategies
Thematic investment baskets across multiple sectors
AI-powered investment analysis and recommendations
Six published research signals averaged into stock ratings
Free access to ratings on the 200 largest US stocks
Company financial analysis and sector comparisons
Stock screening on valuation, profitability, growth and momentum
Rules-based paper portfolio tracking with simulated trading
Custom paper portfolios with historical backtesting
Analyst estimates and DCF valuation tools
CSV export for custom analysis
Rating changes tracked weekly by signal
What makes it different
Diversified sector coverage from AI infrastructure to healthcare staffing
Connects stock screening with company research and paper portfolio tracking in one workspace
Ratings based on six published academic research signals, not proprietary black boxes
Free access to research on largest 200 stocks, no credit card required
Educational research and ranking signals, explicitly not investment advice
Affordable paid plan at $2 first month then $29/month with backtesting and full universe access
Supertake
Tessera Alpha